Outsourcing Pharma
DECEMBER 23, 2020
The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity.
pharmaphorum
DECEMBER 24, 2020
The UK’s COVID-19 vaccination programme could get a speed boost, with the country’s drugs regulator expected to make a decision on a shot from Oxford University/AstraZeneca in the next few days. If the vaccine becomes available the UK will be able to step up its vaccination programme as large swathes of the country face draconian “Tier 4” restrictions due to the emergence of as more infectious variant.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
DECEMBER 22, 2020
Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis
That Frugal Pharmacist
DECEMBER 24, 2020
It’s Christmas Eve 2020. Wow, what a wild year it has been for us all. Socio-political unrest. A more tense than usual election. A global pandemic.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Outsourcing Pharma
DECEMBER 22, 2020
A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug development.
pharmaphorum
DECEMBER 21, 2020
2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% of total M&A deal values. That said, there were still some interesting moves indicating new directions of travel for big pharma players – with most deals focused on specific drugs from biotechs, particularly in cancer (though we did get rumours of an AstraZeneca-Gilead merger , which would have been the
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Mirror
DECEMBER 23, 2020
Davis, CA: Botanical Solution Inc. (BSI), innovator of sustainable, highly consistent and cost effective Advanced Botanical Materials, has successfully secured $3.3 million in a seed round of funding, and is planning another round of funding for Spring 2021. The Spring 2021 Round of funding will boost BSI’s proven ability to discover and develop novel botanical products that are sustainable, highly consistent and cost effective.
Outsourcing Pharma
DECEMBER 23, 2020
Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.
pharmaphorum
DECEMBER 24, 2020
Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, any definitive ‘coming of age’ moment for the sector was unlikely. But that was before the first reports emerged of a highly contagious coronavirus and 2020 will be forever associated with COVID-19 and the global devastation and disruption it has wrought.
Pharma Times
DECEMBER 23, 2020
Drug is being studied in hospitalised COVID-19 patients
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Mirror
DECEMBER 23, 2020
During the last couple of years, medical software has gained a lot of momentum. It’s crucial for monitoring the health of patients, and it’s one of the best ways to put human ingenuity to use. The market for this niche is getting bigger, and it’s going to cross 30 billion dollars soon. Managers and local clinics need to know about all the benefits of using these kinds of programs.
Outsourcing Pharma
DECEMBER 21, 2020
A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.
pharmaphorum
DECEMBER 21, 2020
Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these companies and who is behind them, asks Richard Staines. A year ago, the names Moderna and BioNTech were known mainly to those who followed biotech and pharma dealings. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against t
Pharma Times
DECEMBER 21, 2020
Drug becomes first treatment for peanut allergy in the EU
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
DECEMBER 21, 2020
Stephen Towers, PhD is a leader in medical communications and healthcare marketing, with extensive experience in developing promotional medical education programs and medical affairs initiatives across numerous therapeutic areas and on behalf of diverse US healthcare organizations, from large pharmaceutical companies to smaller biotechs. As VP at Chameleon Communications (part of Omnicom Health Group), he leverages his scientific acumen and pharmaceutical expertise to create impactful scientific
Outsourcing Pharma
DECEMBER 22, 2020
A new survey from the supply-chain analysis company revals inefficiencies, inaccurate data and other flaws can be costly in terms of revenue, reputation and patient lives.
pharmaphorum
DECEMBER 23, 2020
French pharmaceutical company Servier has swooped on Agios Pharma’s marketed and experimental cancer drugs, buying the entire franchise in a deal that leaves the US biopharma focused on genetic disorders. It’s a major change of direction for Boston-based Agios, which has been concentrating on the oncology market since its inception in 2008, bringing the Bristol Myers Squibb-partnered Tibsovo (ivosidenib) for IDH1-mutant acute myeloid leukaemia to the US market.
Pharma Times
DECEMBER 23, 2020
REACH-CDM study was based on results of positive phase II data
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Marketing Network
DECEMBER 21, 2020
Almost two decades after the human genome was sequenced, a trickle of new genetic medicines (i.e., those that modify the expression of an individual’s genes or repair abnormal genes) has entered clinical practice, including 11 RNA therapeutics, 2 in vivo gene therapies, and 2 gene-modified cell therapies. With over 100 late-stage gene therapy trials underway and an increasing number of gene-editing technologies entering trials, it’s clear that this trickle will soon become a torrent.
Outsourcing Pharma
DECEMBER 21, 2020
The pharma firm will lend support to Aqemiaâs high-tech drug discovery tools in order to work on discovery and development of therapies for the virus.
pharmaphorum
DECEMBER 21, 2020
AstraZeneca’s Tagrisso (osimertinib) has been approved by the FDA in a new lung cancer indication that extends its use to a group of patients with early-stage disease. The new use covers adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after a potentially curative operation.
Pharma Times
DECEMBER 23, 2020
Submission supported by results from phase II CodeBreaK 100 study
Med Ed 101
DECEMBER 23, 2020
I had this question the other day about the extent of tiotropium systemic absorption and I had to double-check. I knew that there was some, but wasn’t sure how prevalent it was. According to an older article, the tiotropium systemic absorption is approximately 20% (19.5% to be exact). The more important question is what does […]. The post Tiotropium Systemic Absorption – How Much?
Outsourcing Pharma
DECEMBER 23, 2020
Ovation.io will harness the funding to develop software and data products supporting drug discovery and development, creating diagnostics and more.
pharmaphorum
DECEMBER 23, 2020
It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. But there was some considerable progress in other fields of medicine even though research efforts were diverted away, reports Richard Staines. The American Society of Clinical Oncology (ASCO) annual conference was one of the highlights of the year in cancer research and the fact it was held virtually did not distract from some stunni
Pharma Times
DECEMBER 23, 2020
Payment for drug linked to value to NHS rather than volume used
Med Ed 101
DECEMBER 20, 2020
Diarrhea is a nuisance that can lead to non-adherence to drug therapy. In some cases, diarrhea can be even more than a nuisance and may risk the lives of our patients. Below, I outline my top 5 drugs that cause diarrhea. Metformin When considering drugs that cause diarrhea, I want to give you the most […]. The post My Top 5 Drugs That Cause Diarrhea appeared first on Med Ed 101.
Outsourcing Pharma
DECEMBER 22, 2020
The GoGetTested response operating system, to date used to administer more than 200,000 tests, now will scale to include health systems in more states.
pharmaphorum
DECEMBER 21, 2020
As expected, the FDA has moved swiftly ahead with emergency approval of Moderna’s COVID-19 vaccine after a positive assessment at its vaccines advisory committee. The authorisation means that around six million more vaccine doses can now be rolled out in the US coronavirus immunisation programme, adding to the almost three million doses of Pfizer/BioNTech’s already-approved shot which started to be administered a few days ago.
Pharma Times
DECEMBER 23, 2020
Ebanga approved to treat Ebola in adult and paediatric patients
Pharma Marketing Network
DECEMBER 22, 2020
What will stay the same in 2021? “COVID accelerated our 5-year digital transformation plan into a 5-month plan”. That client comment was amazingly accurate. While initially we saw a great deal of uncertainty with clients all responding differently, by April clients were forming strategic plans to adapt. By July, an intense focus on digital emerged and the rest of 2020 has been a whirlwind of activity as budgets shifted toward digital.
Outsourcing Pharma
DECEMBER 21, 2020
An executive from the digital biomarker tech company explains the myriad benefits of biomarker analysis in advancing precision health solutions.
pharmaphorum
DECEMBER 22, 2020
The UK government is funding a network of three centres that will use digital technology to train the next generation of scientists specialising in advanced therapies. The National Horizons Centre, RoslinCT and the University of Birmingham have been selected as preferred bidders to deliver high impact physical and digitally-delivered training courses as part of the growing Advanced Therapies Skills Training Network (ATSTN) programme.
Expert insights. Personalized for you.
144 
Let's personalize your content